Create a Website Account - Manage notification subscriptions, save form progress and more.
December 21, 2022
Since its discovery in 2009, C. auris has emerged globally as a life-threatening, highly transmissible, often multidrug resistant yeast. In the past year, CDC has published several reports of ongoing transmission of highly resistant strains of C. auris in United States healthcare facilities, particularly in units caring for patients recovering from COVID-19 (4,5,6). Patients with long term acute care and indwelling devices are at highest risk for acquisition. International healthcare is often the initial source of introduction of C. auris to a region. Subsequent healthcare transmission may occur due to shedding in the healthcare environment, resistance of C. auris to standard healthcare disinfectants, and lapses in infection control practices.
As of December 19, 2022, C. auris has not been detected in Washington but represents a serious threat to vulnerable patients. This map has details about where cases have been identified within the U.S. WA DOH performs special surveillance for C. auris by screening isolates submitted from high risk patients and sentinel lab submissions of non-albicans Candida species to the WA Public Health Laboratory for species identification.
Information for this health advisory comes from the Washington State Department of Health’s Health Alert Network (HAN) alert on December 19, 2022.